Devices that are used to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI) are referred to as female pelvic implants. The procedures employed to treat these conditions/disorders involve placing of pelvic implant devices inside the patient’s vagina. The rate of incidence of vaginal disorders is high among elderly population. In most cases, these disorders cause distress, leading to discomfort in the regular life. Surgical procedures utilized to treat POP or SUI may or may not involve the use of female pelvic implants.
Read Report Overview – https://www.transparencymarketresearch.com/female-pelvic-implants-market.html
In case of procedures wherein these implants are employed, the products utilized can be classified into three distinct types: vaginal slings, vaginal mesh implants, and vaginal graft implants. Owing to complex anatomy of the acetabulum and the pelvic ring, complexity of the procedure calls for exact anatomical reduction and hence obtain positive functional results. Thus, implantation of pelvic devices are needed to be performed with utmost meticulousness.
Pelvic organ prolapse and stress urinary incontinence are prevalent among about 80% of women suffering from dysfunction of the pelvic floor. The incidence of pelvic organ prolapse is more common in developing as well as developed countries. According to the Association for Pelvic Organ Prolapse Support, approximately 34 million women suffer from POP across the globe currently. In the U.S., the total number of patients with pelvic organ prolapse is 3.3 million.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57252
According to the National Association for Incontinence, 25 million adult individuals in the U.S. suffer from one or the other form of urinary incontinence, out of which 75% to 80% are women. On the global scale, the number is estimated to be 200 million. Stress urinary incontinence is the most prevalent form of urinary incontinence. In the U.S., the number of adult individuals suffering from SUI is approximately 15 million. Rising prevalence of pelvic organ prolapse and stress urinary incontinence is propelling the female pelvic implants market.
However, increasing rate of complications in pelvic organ prolapse and low rate of efficacy after pelvic implantation are major restraints of the global female pelvic implants market, especially the vaginal mesh implants segment. It has been assessed that one in every 15 women, who have undergone pelvic implantation, has been forced to surgically extract the implant, due to increased complications associated with the vaginal mesh implant. In Australia, approximately 10,000 to 15,000 women suffered from side-effects of using vaginal mesh devices in 2018.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=57252
The global female pelvic implants market can be segmented based on product type, indication type, end-user, and region. In terms of product type, the market can be categorized into vaginal mesh implants, vaginal slings, and vaginal graft implants. Based on indication type, the female pelvic implants market can be divided into pelvic organ prolapse (POP) and stress urinary incontinence (SUI). In terms of end-user, the female pelvic implants market can be classified into hospitals, ambulatory surgical centers, and specialty clinics.
In terms of geography, the global pelvic implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to account for a major share of the global market by the end of 2018, due to favorable rules, regulations, and reimbursement policies of governments and increasing health care expenditure in the region. Europe, followed by Asia Pacific, is projected to be a highly lucrative market for female pelvic implants in the near future. The female pelvic implants market in Asia Pacific is expected to expand rapidly during the forecast period.
Pre Book Female Pelvic Implants Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=57252<ype=S
Increasing population and rising incidence of pelvic organ prolapse and stress urinary incontinence are expected to drive the market in the region in the next few years. Furthermore, increasing awareness among women regarding complications in and treatment of POP and SUI and rising investments in R&D activities in the region are anticipated to promote growth of the female pelvic implants market in Asia Pacific between 2018 and 2026. The pelvic implants market in Middle East & Africa and Latin America is likely to expand substantially during the forecast period, due to introduction of favorable government policies and increase in the expenditure on health care by both public and private bodies in these regions.
Key players operating in the global female pelvic implants market are Johnson & Johnson Services, Inc., Coloplast Group, BD (Becton, Dickinson and Company), Boston Scientific Corporation, PFM Medical AG, Cook, Betatech Medical, Dipromed Srl, Promedon, and Caldera Medical.
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
